Financial reports
ARS
2023 FY
Annual report to shareholders
23 Apr 24
10-K
2023 FY
Annual report
14 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
ARS
2022 FY
Annual report to shareholders
20 Apr 23
10-K
2022 FY
Annual report
6 Mar 23
10-Q
2022 Q3
Quarterly report
7 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
6 May 22
Current reports
8-K
Departure of Directors or Certain Officers
23 Apr 24
8-K
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
14 Mar 24
8-K
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024
26 Feb 24
8-K
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition
12 Feb 24
8-K
Regulation FD Disclosure
2 Feb 24
8-K
Regulation FD Disclosure
16 Jan 24
8-K
Allakos Announces a Restructuring to Focus on Development of AK006
16 Jan 24
8-K
Allakos Provides Business Update and Reports Third Quarter 2023 Financial Results
13 Nov 23
8-K
Allakos Appoints Neil Graham to its Board of Directors
30 Aug 23
8-K
Amendments to Articles of Incorporation or Bylaws
21 Aug 23
Registration and prospectus
S-8
Registration of securities for employees
5 Jan 24
S-3
Shelf registration
13 Nov 23
S-8
Registration of securities for employees
5 Jan 23
424B5
Prospectus supplement for primary offering
19 Sep 22
424B5
Prospectus supplement for primary offering
4 Aug 22
424B3
Prospectus supplement
31 May 22
S-3
Shelf registration
19 May 22
RW
Registration withdrawal request
19 May 22
S-3ASR
Automatic shelf registration
6 May 22
S-8
Registration of securities for employees
15 Feb 22
Proxies
DEF 14A
Definitive proxy
23 Apr 24
DEF 14A
Definitive proxy
20 Apr 23
DEF 14A
Definitive proxy
14 Apr 22
DEF 14A
Definitive proxy
14 Apr 21
DEF 14A
Definitive proxy
15 Apr 20
DEF 14A
Definitive proxy
30 Apr 19
Other
EFFECT
Notice of effectiveness
27 Nov 23
UPLOAD
Letter from SEC
17 Nov 23
CORRESP
Correspondence with SEC
17 Nov 23
EFFECT
Notice of effectiveness
1 Jun 22
CORRESP
Correspondence with SEC
26 May 22
UPLOAD
Letter from SEC
25 May 22
EFFECT
Notice of effectiveness
19 Jul 18
CT ORDER
Confidential treatment order
18 Jul 18
CORRESP
Correspondence with SEC
17 Jul 18
CERT
Certification of approval for exchange listing
16 Jul 18
Ownership
144
Notice of proposed sale of securities
19 Mar 24
4
Harlan Baird Radford
7 Mar 24
4
Adam Tomasi
6 Mar 24
4
Robert Alexander
6 Mar 24
144
Notice of proposed sale of securities
6 Mar 24
144
Notice of proposed sale of securities
5 Mar 24
144
Notice of proposed sale of securities
4 Mar 24
4
Harlan Baird Radford
21 Feb 24
4
Chin Hyok Lee
21 Feb 24
4
Robert Alexander
21 Feb 24